{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:11:19Z","timestamp":1778555479449,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,10]],"date-time":"2015-01-10T00:00:00Z","timestamp":1420848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jsps.2015.01.001","type":"journal-article","created":{"date-parts":[[2015,1,10]],"date-time":"2015-01-10T15:36:25Z","timestamp":1420904185000},"page":"377-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Clinical treatment of pandrug-resistant bacterial infection consulted by clinical pharmacist"],"prefix":"10.1007","volume":"23","author":[{"given":"Yang","family":"Zhi-Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Yan-Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wei-Jun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"3","key":"10.1016\/j.jsps.2015.01.001_b0045","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1128\/AAC.01097-08","article-title":"In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi-andpandrug-resistantclinical isolates of Acinetobacter baumannii group","volume":"53","author":"Arroyo","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.jsps.2015.01.001_b0015","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1128\/JCM.38.11.4086-4095.2000","article-title":"Emergence and rapid spread of carbapenem resistance during a large and sustained hospital out-break of multi-resistant Acinetobacter baumannii","volume":"38","author":"Corbella","year":"2000","journal-title":"J. Clin. Microbiol."},{"issue":"30","key":"10.1016\/j.jsps.2015.01.001_b0025","first-page":"2878","article-title":"Pharmaceutical care analysis of critical patients multi-drug resistance acinetobacter baumannii infection","volume":"21","author":"Dong","year":"2010","journal-title":"China Pharmacy"},{"issue":"5","key":"10.1016\/j.jsps.2015.01.001_b0050","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/AAC.02399-12","article-title":"Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producingpandrug-resistantKlebsiella pneumoniae","volume":"57","author":"Giamarellou","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"22","key":"10.1016\/j.jsps.2015.01.001_b0035","first-page":"2098","article-title":"Clinical pharmacists consultation multi-drug resistance and pandrug-resistant bacterial infection 79 cases analysis","volume":"22","author":"Liang","year":"2011","journal-title":"China Pharmacy"},{"key":"10.1016\/j.jsps.2015.01.001_b0010","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1099\/jmm.0.46747-0","article-title":"The diversity of definitions of Multi drug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"55","author":"Matthew","year":"2006","journal-title":"J. Med. Microbiol."},{"issue":"2","key":"10.1016\/j.jsps.2015.01.001_b0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/cid\/cir323","article-title":"The challenges of antimicrobial drug resistance in Greece","volume":"53","author":"Miyakis","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.jsps.2015.01.001_b0020","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/jac\/dku027","article-title":"Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections","volume":"69","author":"Oliva","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.jsps.2015.01.001_b0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijantimicag.2013.09.010","article-title":"Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due topandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria","volume":"43","author":"Pontikis","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jsps.2015.01.001_b0005","doi-asserted-by":"crossref","DOI":"10.1007\/s10096-014-2124-9","article-title":"Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review","author":"Poulikakos","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"54","key":"10.1016\/j.jsps.2015.01.001_b0040","first-page":"17","article-title":"Multi-drug resistance acinetobacter baumannii therapy exploration","volume":"9","author":"Shiying","year":"2006","journal-title":"China Prescript. Drug"},{"issue":"3","key":"10.1016\/j.jsps.2015.01.001_b0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10096-009-0857-7","article-title":"Infections bypandrug-resistantgram-negative bacteria: clinical profile, therapeutic management, and outcome in a series of 21 patients","volume":"29","author":"Tsioutis","year":"2010","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S131901641500002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S131901641500002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:28:21Z","timestamp":1736184501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S131901641500002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S131901641500002X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2015.01.001","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical treatment of pandrug-resistant bacterial infection consulted by clinical pharmacist","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2015.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}